N/A
N=207
Long-Term Patient Satisfaction of Facial Aesthetic Treatment With BOTOX®
Glabellar Lines
Bottom Line
View on ClinicalTrials.gov: NCT01608672 ↗Enrolled (actual)
207
Serious AEs
0.0%
Results posted
Dec 2013
Primary outcome: Primary: Percentage of Participants Mostly or Very Satisfied With Their Glabellar Lines on the Facial Line Satisfaction Questionnaire (FLSQ) — 92.3 Percentage of participants
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- botulinum toxin Type A (Biological)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Allergan
- Primary completion
- Dec 2012
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Percentage of Participants Mostly or Very Satisfied With Their Glabellar Lines on the Facial Line Satisfaction Questionnaire (FLSQ) |
92.3 | — |
| SECONDARY Percentage of Participants Mostly or Very Satisfied With Effectiveness of ≥ 5 Years BOTOX® Treatments Using the Patient Questionnaire |
95.8 | — |
| SECONDARY Percentage of Participants Where Physician Was Mostly or Very Satisfied With Effectiveness of ≥ 5 Years BOTOX® Treatments Using the Physician Questionnaire |
98.0 | — |
Summary
This is an observational study assessing patient satisfaction following at least 5 years of BOTOX® treatment for glabellar lines.
Eligibility Criteria
Inclusion Criteria
- At least one BOTOX® treatment for facial wrinkles (glabellar lines) per calendar year for ≥5 years
Exclusion Criteria
- Received botulinum toxin formulations other than BOTOX®
Data sourced from ClinicalTrials.gov (NCT01608672). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.